Clinical Trial: A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264335) titled 'A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects' on Nov. 24.

Brief Summary: This study is a randomized, parallel-group, open-label Phase I clinical trial designed to compare the bioavailability and safety of subcutaneous SHR-1819 injection administered via different injection devices in healthy subjects.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis

Intervention: DRUG: SHR-1819 Injection

SHR-1819 injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Publ...